ASH Clinical News July 2017 V2 - Page 7

VOLUME 03 | NUMBER 08 | JULY 2017 Around the Network AMERICAN SOCIETY OF HEMATOLOGY (ASH) HEADQUARTERS 2021 L Street NW, Suite 900 Washington, DC 20036 www.hematology.org Tel: 202-776-0544 IN THIS ISSUE EDITOR-IN-CHIEF Mikkael Sekeres, MD, MS drawing first blood Is MRD Testing Worthwhile in Myeloma? ASSOCIATE EDITORS The ability to measure minimal residual disease (MRD) after therapy has the potential to help guide treatment decisions and predict patients’ likelihood of relapse, but is MRD monitoring ready to be used in routine clinical prac- tice? Faith Davies, MD, and Saad Z. Usmani, MD, debate the question, “Is measuring MRD worthwhile in myeloma?” Vice-Chair for Clinical Research Director, Leukemia Program Cleveland Clinic, Taussig Cancer Institute Cleveland, OH Beth Faiman, CNP, PhD 42 Alice Ma, MD clinical news Cleveland Clinic Cleveland, OH University of North Carolina School of Medicine Chapel Hill, NC David Steensma, MD Dana-Farber Cancer Institute Boston, MA Keith Stewart, MBChB, MBA Mayo Clinic Scottsdale, AZ The Power of Collaboration Richard Pazdur, MD, director of the U.S. Food and Drug Administration’s newly established Oncology Center of Excellence, discusses the center’s integrative, innovative approach to bringing hematology/oncology products to patients. 36 16  CD19-Directed CAR T-Cell Therapy in Young Patients With ALL 23  Finding the Best VTE Prophylaxis Options for Patients Undergoing Hip and Knee Surgery 28  On Location: Hematology Highlights from the 2017 ASCO Annual Meeting PUBLISHER American Medical Communications (AMC) EDITORIAL MANAGING EDITORS Kristin Hubing, ASH Ariel Jones-DeMaio, AMC ASSOCIATE MANAGING EDITOR Kerri Fitzgerald, AMC EDITORIAL ASSOCIATE Laurie Adamson, ASH ART DIRECTOR Ari Mihos ASSISTANT ART DIRECTORS Charlene DePrizio John Salesi DIGITAL PROJECTS MANAGER Chris Gedikli ASHCLINICALNEWS.ORG @ASHCLINICALNEWS Did you miss any of the hematology highlights reported at the 2017 ASCO Annual Meeting? Visit ashclinicalnews.org/meeting- coverage to watch all of our exclusive interviews with presenters. You can also find all of our online- only coverage at ashclinicalnews.org/ on-location. And, be sure to check out our special mid-July issue for more of our coverage of this meeting, as well as the 22nd Congress of the European Hematology Association. After the ASCO Annual Meeting ends, we’ll be sharing all of our coverage on Twitter, so stay in the loop by following us at @ASHClinicalNews. Make sure to sign up for our e-newsletters to have the latest updates delivered to your inbox. Visit ashclinicalnews.org to sign up! ADVERTISING ACCOUNT MANAGER Nick Luciano nluciano@americanmedicalcomm.com Gene Conselyea gconselyea@americanmedicalcomm.com Recruitment advertising orders can be sent to: DIRECTOR, RECRUITMENT CLASSIFIEDS Lauren Morgan lmorgan@americanmedicalcomm.com Visit us at ashclinicalnews.org Follow us on Twitter @ASHClinicalNews ©2017 by the American Society of Hematology. All materials contained in this newsletter are protected by copyright laws and may not be used, reproduced, or oth- erwise exploited in any manner without the express prior written permission of ASH Clinical News. Any third-party materials communicated to ASH Clinical News become its copyrighted property and may be used, reproduced, or otherwise exploited by ASH Clinical News. ASHClinicalNews.org YOU MAKE THE CALL WINNER Announcing last month’s “You Make the Call - Readers’ Response” winner: John Maddox, MD Hope you enjoy your prize! For your chance to win, be sure to send in your response to each month's You Make the Call question! Subscription inquiries should be sent to: cwittholt@americanmedicalcomm.com All correspondence for the American Society of Hematology should be sent to: American Society of Hematology, 2021 L Street NW, Suite 900, Washington DC 20036. Neither the American Society of Hematology nor the publisher is responsible for statements made by any editor or contributor. Statements, editorials, or opinions expressed in ASH Clinical News magazine do not necessarily represent official policy of the American Society of Hematology unless so stated. No responsibility is as- sumed by the American Society of Hematology or the Publisher for any injury or damage to persons or property as a matter of product liability, negligence or otherwise or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Although all advertising material published in ASH Clinical News magazine is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement by the American Society of Hematology or the Publisher of the quality or value of such product or of the claim made of it by its manufacturer. About the American Society of Hematology The American Society of Hematology (ASH) is the world’s largest professional society concerned with the causes and treatments of blood disorders. The mission of the Society is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. ASH Clinical News (ISSN 2375-8120) is published once per month by American Medical Communications, 630 Madison Avenue, 2nd Floor, Manalapan, NJ 07726. Periodicals postage is pending/paid at Manalapan, NJ and additional mailing offices. POSTMASTER: Send address changes to American Medical Communications, 630 Madison Avenue, 2nd Floor, Manalapan, NJ 07726. ©Copyright, 2016. ASH Clinical News 5